News
Press releases & media coverage on the latest updates and breakthroughs from the Beacon team.
Beacon Biosignals Completes Strategic Transaction to Acquire CleveMed
Beacon Biosignals
Beacon Biosignals Reports Novel Sleep EEG Results from Multiple Industry Collaborations at the American Epilepsy Society Annual Meeting
Beacon Biosignals
FDA Authorizes Beacon’s Dreem 3S as First Sleep Wearable with Predetermined Change Control Plan, Paving the Way for Continuous Algorithm Enhancements in Sleep Monitoring
Beacon Biosignals
Beacon Launches HEADFIRST Clinical Trial to Study Sleep EEG in Pediatric Developmental Disorders, Partners with LGS Foundation
Beacon Biosignals
Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
Beacon Biosignals
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
Beacon Biosignals
Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders
Beacon Biosignals
Beacon Biosignals Expands Sleep Analysis Capabilities with FDA Clearance of SleepStageML
Beacon Biosignals
Beacon Biosignals welcomes David Matthews, PhD, as Chief Business Officer
Beacon Biosignals
Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
Beacon Biosignals
Beacon Biosignals Elevates Brain Health Understanding at AES 2023
Beacon Biosignals
Beacon Biosignals lights the way to FDA nod for AI-powered sleep monitoring headset
Fierce Biotech
Beacon Biosignals Receives FDA Clearance for AI-Assisted Sleep Monitoring Device Dreem 3S
Beacon Biosignals
Beacon Biosignals Acquires Dreem, Launches At-home Sleep Monitoring Services for Clinical Trials
Beacon Biosignals
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Beacon Biosignals
Research from Beacon Biosignals presented at Alzheimer's Association International Conference
PR Newswire
Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics
PR Newswire
Startups are turning to a century-old technology to fuel a resurgence in neuro drug development
STAT
34 healthcare and biotech startups that are set to take off in 2022, according to top investors
Business Insider
Beacon Biosignals raises $27 Million Series A led by General Catalyst to scale its EEG neurobiomarker discovery platform
PR Newswire
Beacon Biosignals raises $27M to find brain-based biomarkers
Boston Business Journal
Cyclerion Recruits Beacon Biosignals To Identify Disease-Relevant EEG Neurological Biomarkers
Yahoo News
Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership
PR Newswire
